These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32224756)

  • 1. The Evolving Concept of Cryptogenic Stroke.
    Kamel H
    Continuum (Minneap Minn); 2020 Apr; 26(2):353-362. PubMed ID: 32224756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
    Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
    Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM; Carroll JD
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
    Nasir UB; Qureshi WT; Jogu H; Wolfe E; Dutta A; Majeed CN; Tan WA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):187-193. PubMed ID: 30905408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.
    Umemura T; Nishizawa S; Nakano Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1810-1815. PubMed ID: 31097326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closure of Patent Foramen Ovale and Cryptogenic Stroke: Unresolved Issues.
    Diener HC; Gerloff C; Thaler DE; Wöhrle J
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):92. PubMed ID: 30328522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
    Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
    Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.
    Mas JL; Derumeaux G; Amarenco P; Arquizan C; Aubry P; Barthelet M; Bertrand B; Brochet E; Cabanes L; Donal E; Dubois-Randé JL; Durand-Zaleski I; Ernande L; Finet G; Fraisse A; Giroud M; Guérin P; Habib G; Juliard JM; Leys D; Lièvre M; Lusson JR; Marcon F; Michel P; Moulin T; Mounier-Vehier F; Pierard L; Piot C; Rey C; Rodier G; Roudaut R; Schleich JM; Teiger E; Turc G; Vuillier F; Weimar C; Woimant F; Chatellier G;
    Int J Stroke; 2016 Aug; 11(6):724-32. PubMed ID: 27056964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Closure of the patent foramen ovale (PFO) in cryptogenic stroke].
    Diener HC; Knebel F
    Herz; 2019 Jun; 44(4):304-309. PubMed ID: 30941472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.
    Kotadia ID; Sim I; Mukherjee R; O'Hare D; Chiribiri A; Birns J; Bhalla A; O'Neill M; Williams SE
    J Am Heart Assoc; 2021 Jul; 10(13):e021045. PubMed ID: 34212774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
    Diener HC; Bernstein R; Hart R
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke].
    Donti A; Egidy Assenza G; Mariucci E
    G Ital Cardiol (Rome); 2019 Feb; 20(2):73-84. PubMed ID: 30747923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: Insights from insertable cardiac monitors.
    Verma N; Ziegler PD; Liu S; Passman RS
    Int J Stroke; 2019 Feb; 14(2):146-153. PubMed ID: 30196791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Management for Secondary Stroke Prevention.
    Kim AS
    Continuum (Minneap Minn); 2020 Apr; 26(2):435-456. PubMed ID: 32224760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke.
    Smer A; Salih M; Mahfood Haddad T; Guddeti R; Saadi A; Saurav A; Belbase R; Ayan M; Traina M; Alla V; Del Core M
    Am J Cardiol; 2018 Jun; 121(11):1393-1399. PubMed ID: 29680170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis.
    Angelini F; Fortuni F; Tsivgoulis G; Agnelli G; Bocchino PP; Franchin L; De Filippo O; Bellettini M; D'Ascenzo F; Crimi G; Leonardi S; De Ferrari GM; Paciaroni M
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):987-993. PubMed ID: 32918655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.